Forecast & Rating2 analysts currently cover CytoSorbents, of which 0 give a positive rating. The average price target is $2.38, about 541.9% upside from the current price of $0.37. Coverage is limited, so the data is for reference only. Data as of Aug 17, 2026; this does not constitute investment advice.
Aug 17, 2026Price forecast
$2.38541.89%
Forecast & RatingHold
1analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 16, 2026
Forecast met0.0%
Stock price$0.37
Avg. target$4.9
High target$10
Low target$1
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.